{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:56:02Z","timestamp":1793404562315,"version":"4.5.0"},"reference-count":73,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","funder":[{"name":"MUHC OBGYN Academic enrichment fund","award":["1"],"award-info":[{"award-number":["1"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To estimate the effect of medical management on the size of ovarian endometriomas.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DATA SOURCE:<\/jats:title>\n                    <jats:p>Online databases were searched from inception to October 2022, including Ovid MEDLINE, Ovid EMBASE, PubMed, EBM Reviews\u2014Cochrane Central Register of Controlled Trials (CENTRAL), ClinicalTrials.gov, and Web of Science.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS OF STUDY SELECTION:<\/jats:title>\n                    <jats:p>Following PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines, we included all English-language, full-text articles that reported on change in endometrioma size (either diameter or volume) after medical interventions. Studies evaluating surgical interventions or postoperative recurrence were excluded. All screening and data extraction were performed independently by two authors. Risk of bias assessment was performed with either the Cochrane Risk of Bias Tool for randomized controlled trials or a modified Newcastle-Ottawa Scale for observational studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>TABULATION, INTEGRATION, AND RESULTS:<\/jats:title>\n                    <jats:p>After removal of duplicates, 9,332 studies were screened, with 33 full-text articles deemed eligible for inclusion. In the meta-analysis, dienogest showed significant reduction in cyst diameter (reduction 1.32 cm, 95% CI, 0.91\u20131.73, eight studies, n=418 cysts) and volume (mean difference of log-transformed volume 1.35, 95% CI, 0.87\u20131.83, seven studies, n=282 cysts). Similarly, significant reductions were seen with the oral contraceptive pill (OCP) (1.06 cm, 95% CI, 0.59\u20131.53, nine studies, n=455), gonadotropin-releasing hormone (GnRH) agonists (1.17 cm, 95% CI, 0.42\u20131.92, four studies, n=128 cysts), norethindrone acetate (0.6 cm, 95% CI, 0.27\u20130.94, two studies, n=88 cysts), and danazol (1.95 cm, 95% CI, 1.18\u20132.73, two studies, n=34 cysts). Norethindrone acetate with aromatase inhibitor was also effective in reducing endometrioma volume (mean difference of log-transformed volume 1.47, 95% CI, 0.16\u20132.78, two studies, n=34 cysts).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Medical management with dienogest, OCPs, GnRH agonists, norethindrone acetate, norethindrone acetate with aromatase inhibitor, or danazol can reduce the size of ovarian endometriomas.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SYSTEMATIC REVIEW REGISTRATION:<\/jats:title>\n                    <jats:p>PROSPERO, CRD 42022363319.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000005444","type":"journal-article","created":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T17:09:05Z","timestamp":1699549745000},"page":"53-66","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":24,"title":["Medical Management of Ovarian Endometriomas"],"prefix":"10.1097","volume":"143","author":[{"given":"Alexa","family":"Eberle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Bach","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica Papillon","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fady W.","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivasan","family":"Krishnamurthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Zakhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,11,9]]},"reference":[{"key":"R1-20260916","first-page":"1","article-title":"Risk for and consequences of endometriosis: a critical epidemiologic review","volume":"51","author":"Shafrir","year":"2018","journal-title":"Res Clin Obstet Gynaecol"},{"key":"R2-20260916","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/uog.7668","article-title":"Endometriomas: their ultrasound characteristics","volume":"35","author":"Van Holsbeke","year":"2010","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R3-20260916","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.fertnstert.2013.03.033","article-title":"Ovarian damage after laparoscopic endometrioma excision might be related to the size of cyst","volume":"100","author":"Tang","year":"2013","journal-title":"Fertility Sterility"},{"key":"R4-20260916","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1080\/01443615.2020.1867962","article-title":"Dienogest reduces endometrioma volume and endometriosis-related pain symptoms","volume":"41","author":"Uludag","year":"2021","journal-title":"Obstet Gynaecol"},{"key":"R5-20260916","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/aogs.13114","article-title":"An update on the diagnosis, surgical management, and fertility outcomes for women with endometrioma","volume":"96","author":"Cranney","year":"2017","journal-title":"Acta Obst Scand"},{"key":"R6-20260916","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12905-021-01545-5","article-title":"Treatment of endometriosis: a review with comparison of 8 guidelines","volume":"21","author":"Kalaitzopoulos","year":"2021","journal-title":"BMC Womens Health"},{"key":"R7-20260916","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1080\/09513590.2019.1640674","article-title":"Is dienogest the best medical treatment for ovarian endometriomas? Results of a multicentric case control study","volume":"36","author":"Angioni","year":"2020","journal-title":"Gynecol Endocrinol"},{"key":"R8-20260916","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.rbmo.2020.07.022","article-title":"Pretreatment with dienogest in women with endometriosis undergoing IVF after a previous failed cycle","volume":"41","author":"Barra","year":"2020","journal-title":"BioMedicine Online"},{"key":"R9-20260916","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ejogrb.2019.04.010","article-title":"Dienogest or norethindrone acetate for the treatment of ovarian endometriomas: can we avoid surgery?","volume":"238","author":"Del Forno","year":"2019","journal-title":"J Obstet Gynecol Reprod Biol"},{"key":"R10-20260916","doi-asserted-by":"crossref","first-page":"151","DOI":"10.5301\/je.5000167","article-title":"Do low-dose oral contraceptives have an effect on ovarian endometrioma diameter and endometriosis symptoms?","volume":"5","author":"Del Forno","year":"2013","journal-title":"J Endometriosis Pelvic Pain Disord"},{"key":"R11-20260916","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejogrb.2013.11.030","article-title":"Norethisterone acetate versus norethisterone acetate combined with letrozole for the treatment of ovarian endometriotic cysts: a patient preference study","volume":"174","author":"Ferrero","year":"2014","journal-title":"J Obstet Gynecol Reprod Biol"},{"key":"R12-20260916","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3109\/09513590.2011.634936","article-title":"A new oral contraceptive regimen for endometriosis management: preliminary experience with 24\/4-day drospirenone\/ethinylestradiol 3 mg\/20 mcg","volume":"28","author":"Mabrouk","year":"2012","journal-title":"Gynecol Endocrinol"},{"key":"R13-20260916","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/09513590.2019.1640199","article-title":"Medical treatment of ovarian endometriomas: a prospective evaluation of the effect of dienogest on ovarian reserve, cyst diameter, and associated pain","volume":"36","author":"Muzii","year":"2020","journal-title":"Gynecol Endocrinol"},{"key":"R14-20260916","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/09513590.2021.1892632","article-title":"Dienogest versus continuous oral levonorgestrel\/EE in patients with endometriosis: what's the best choice?","volume":"37","author":"Piacenti","year":"2021","journal-title":"Gynecol Endocrinol"},{"key":"R15-20260916","first-page":"240702","article-title":"A promise in the treatment of endometriosis: an observational cohort study on ovarian endometrioma reduction by N-acetylcysteine","volume":"2013","author":"Porpora","year":"2013","journal-title":"Altern Med"},{"key":"R16-20260916","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1080\/09513590.2020.1725965","article-title":"Effect of Dienogest therapy on the size of the endometrioma","volume":"36","author":"Vignali","year":"2020","journal-title":"Gynecol Endocrinol"},{"key":"R17-20260916","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1080\/09513590.2019.1703942","article-title":"Modification of endometrioma size during hormone therapy containing dienogest","volume":"36","author":"Xholli","year":"2020","journal-title":"Gynecol Endocrinol"},{"key":"R18-20260916","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1080\/09513590.2021.1903420","article-title":"Estradiol\/nomegestrol acetate as a first-line and rescue therapy for the treatment of ovarian and deep infiltrating endometriosis","volume":"37","author":"MarianiNovara","year":"2021","journal-title":"Gynecol Endocrinol"},{"key":"R19-20260916","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.fertnstert.2017.07.1165","article-title":"Ethinylestradiol 20 \u03bcg\/drospirenone 3 mg in a flexible extended regimen for the management of endometriosis-associated pelvic pain: a randomized controlled trial","volume":"108","author":"Harada","year":"2017","journal-title":"Fertility Sterility"},{"key":"R20-20260916","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.fertnstert.2007.08.051","article-title":"Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial","volume":"90","author":"Harada","year":"2008","journal-title":"Fertility Sterility"},{"key":"R21-20260916","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.fertnstert.2021.11.013","article-title":"Relugolix, an oral gonadotropin-releasing hormone receptor antagonist, reduces endometriosis-associated pain compared with leuprorelin in Japanese women: a phase 3, randomized, double-blind, noninferiority study","volume":"117","author":"Harada","year":"2022","journal-title":"Fertility Sterility"},{"key":"R22-20260916","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/rmb2.12391","article-title":"An assessment of the efficacy and safety of dydrogesterone in women with ovarian endometrioma: An assessment of the efficacy and safety of dydrogesterone in women with ovarian endometrioma: an open-label multicenter clinical study","volume":"20","author":"Kitawaki","year":"2021","journal-title":"Repro Med Biol"},{"key":"R23-20260916","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3109\/09513590.2014.911277","article-title":"Prediction of the therapeutic effect of dienogest in ovarian endometrial cysts using the apparent diffusion coefficient","volume":"30","author":"Matsuura","year":"2014","journal-title":"Gynecol Endocrinol"},{"key":"R24-20260916","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1111\/jog.12811","article-title":"Use of dienogest over 53 weeks for the treatment of endometriosis","volume":"41","author":"Sugimoto","year":"2015","journal-title":"J Obstet Gynaecol Res"},{"key":"R25-20260916","doi-asserted-by":"crossref","first-page":"398","DOI":"10.12891\/ceog4720.2019","article-title":"Long-term treatment of endometriosis with dienogest for up to five years","volume":"46","author":"Takagi","year":"2019","journal-title":"Exp Obstet Gynecol"},{"key":"R26-20260916","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1447-0756.2000.tb01334.x","article-title":"A prospective randomized study comparing endocrinological and clinical effects of two types of GnRH agonists in cases of uterine leiomyomas or endometriosis","volume":"26","author":"Takeuchi","year":"2000","journal-title":"Obstet Gynaecol Res"},{"key":"R27-20260916","doi-asserted-by":"crossref","first-page":"182","DOI":"10.33160\/yam.2017.09.008","article-title":"Efficacy of norethisterone in patients with ovarian endometrioma","volume":"60","author":"Taniguchi","year":"2017","journal-title":"Yonago Acta Med"},{"key":"R28-20260916","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejogrb.2015.06.006","article-title":"Effects of low dose oral contraceptive pill containing drospirenone\/ethinylestradiol in patients with endometrioma","volume":"191","author":"Taniguchi","year":"2015","journal-title":"J Obstet Gynecol Reprod Biol"},{"key":"R29-20260916","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/j.1447-0756.2009.01017.x","article-title":"The efficacy of preoperative hormonal therapy before laparoscopic cystectomy of ovarian endometriomas","volume":"35","author":"Tsujioka","year":"2009","journal-title":"Obstet Gynaecol Res"},{"key":"R30-20260916","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/09513590.2022.2053956","article-title":"A prospective study examining the effect of dienogest treatment on endometrioma size and symptoms","volume":"38","author":"Kizilkaya","year":"2022","journal-title":"Gynecol Endocrinol"},{"key":"R31-20260916","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/ajo.12773","article-title":"The levonorgestrel\u2010releasing intrauterine system is associated with a reduction in dysmenorrhoea and dyspareunia, a decrease in CA 125 levels, and an increase in quality of life in women with suspected endometriosis","volume":"58","author":"Yucel","year":"2018","journal-title":"New Zealand J Obstet Gynaecol"},{"key":"R32-20260916","doi-asserted-by":"crossref","first-page":"878517","DOI":"10.1155\/2015\/878517","article-title":"Reduction in endometrioma size with three months of aromatase inhibition and progestin add-back","volume":"2015","author":"Agarwal","year":"2015","journal-title":"BioMed Res Inter"},{"key":"R33-20260916","first-page":"384","article-title":"Decrease in the size of ovarian endometriomas during ovarian suppression in stage IV endometriosis. Role of preoperative medical treatment","volume":"41","author":"Rana","year":"1996","journal-title":"J Reprod Med"},{"key":"R34-20260916","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1148\/radiology.175.2.2109336","article-title":"Monitoring therapy with a gonadotropin-releasing hormone analog: utility of MR imaging","volume":"175","author":"Zawin","year":"1990","journal-title":"Radiology"},{"key":"R35-20260916","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s13224-021-01483-0","article-title":"Role of dienogest in endometriosis in young women","volume":"71","author":"Malik","year":"2021","journal-title":"J India Obstet Gynecol India"},{"key":"R36-20260916","first-page":"237","article-title":"Long-acting triptorelin for the treatment of endometriosis","volume":"54","author":"Choktanasiri","year":"1996","journal-title":"J Gynecol Obstet"},{"key":"R37-20260916","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejogrb.2009.02.001","article-title":"Combined down-regulation by aromatase inhibitor and GnRH-agonist in IVF patients with endometriomas\u2014a pilot study","volume":"144","author":"Lossl","year":"2009","journal-title":"J Obstet Gynecol Reprod Biol"},{"key":"R38-20260916","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00404-014-3242-4","article-title":"Does cabergoline help in decreasing endometrioma size compared to LHRH agonist? A prospective randomized study","volume":"290","author":"Hamid","year":"2014","journal-title":"Arch Obstet"},{"key":"R39-20260916","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1080\/03007995.2020.1744120","article-title":"Use of dienogest in endometriosis: a narrative literature review and expert commentary","volume":"36","author":"Murji","year":"2020","journal-title":"Curr Res Opin"},{"key":"R40-20260916","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.fertnstert.2018.03.012","article-title":"Use of combined hormonal contraceptives for the treatment of endometriosis-related pain: a systematic review of the evidence","volume":"110","author":"Jensen","year":"2018","journal-title":"Fertility Sterility"},{"key":"R41-20260916","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/molehr\/gap042","article-title":"Dienogest, a synthetic progestin, inhibits the proliferation of immortalized human endometrial epithelial cells with suppression of cyclin D1 gene expression","volume":"15","author":"Shimizu","year":"2009","journal-title":"Mol Reprod"},{"key":"R42-20260916","doi-asserted-by":"crossref","first-page":"83334","DOI":"10.18632\/oncotarget.19833","article-title":"Antiandrogenic and antimineralocorticoid health benefits of COC containing newer progestogens: dienogest and drospirenone","volume":"8","author":"Regidor","year":"2017","journal-title":"Oncotarget"},{"issue":"Suppl 3","key":"R43-20260916","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/13697130500330382","article-title":"Pharmacology of different progestogens: the special case of drospirenone","volume":"8","author":"Sitruk-Ware","year":"2005","journal-title":"Climacteric"},{"key":"R44-20260916","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.2165\/11206320-000000000-00000","article-title":"Dienogest: a review of its use in the treatment of endometriosis","volume":"70","author":"McCormack","year":"2010","journal-title":"Drugs"},{"key":"R45-20260916","first-page":"341","article-title":"The inhibitory effect of dienogest, a synthetic steroid, on the growth of human endometrial stromal cells in vitro","volume":"7","author":"Okada","year":"2001","journal-title":"MHR"},{"key":"R46-20260916","doi-asserted-by":"crossref","first-page":"1745506520952003","DOI":"10.1177\/1745506520952003","article-title":"Dienogest suppresses cellular proliferation status of endometrial polyps and acts differently depending on the morphological type","volume":"16","author":"Inaba","year":"2020","journal-title":"Women's Health"},{"key":"R47-20260916","doi-asserted-by":"crossref","first-page":"hoac009","DOI":"10.1093\/hropen\/hoac009","article-title":"ESHRE guideline: endometriosis","volume":"2022","author":"Becker","year":"2022","journal-title":"Hum Reproduct"},{"key":"R48-20260916","first-page":"556","article-title":"Diagnosis and management of endometriosis: a systematic review of international and national guidelines","volume":"125","author":"Hirsch","year":"2018","journal-title":"J Obstet Gynaecol"},{"key":"R49-20260916","doi-asserted-by":"crossref","first-page":"938606","DOI":"10.3389\/fmed.2022.938606","article-title":"Effect and safety of drospirenone and ethinylestradiol tablets (II) for dysmenorrhea: Effect and safety of drospirenone and ethinylestradiol tablets (II) for dysmenorrhea: A systematic review and meta-analysis systematic review and meta-analysis","volume":"9","author":"Shi","year":"2022","journal-title":"Front Med"},{"key":"R51-20260916","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2147\/OAJC.S183193","article-title":"Contraception counseling for women with premenstrual dysphoric disorder (PMDD): current perspectives","volume":"10","author":"Rapkin","year":"2019","journal-title":"Open Acc J Contraception"},{"key":"R52-20260916","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.contraception.2009.10.010","article-title":"Bleeding patterns and menstrual-related symptoms with the continuous use of a contraceptive combination of ethinylestradiol and drospirenone: a randomized study","volume":"81","author":"Machado","year":"2010","journal-title":"Contraception"},{"key":"R53-20260916","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.contraception.2008.12.007","article-title":"Bleeding pattern, tolerance and patient satisfaction with a drospirenone-containing oral contraceptive evaluated in 3488 women in Europe, the Middle East and Canada","volume":"79","author":"Endrikat","year":"2009","journal-title":"Contraception"},{"key":"R54-20260916","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jmig.2006.06.026","article-title":"Danazol treatment of endometriosis-associated pain","volume":"13","author":"Luciano","year":"2006","journal-title":"J Minimally Invasive Gynecol"},{"key":"R55-20260916","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMct0803719","article-title":"Gonadotropin-releasing hormone agonists for endometriosis","volume":"359","author":"Olive","year":"2008","journal-title":"New England J Med"},{"key":"R56-20260916","first-page":"709","article-title":"Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up","volume":"99","author":"Surrey","year":"2002","journal-title":"Obstetrics Gynecol"},{"key":"R57-20260916","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/humupd\/dmaa033","article-title":"Endometriosis recurrence following post-operative hormonal suppression: a systematic review and meta-analysis","volume":"27","author":"Zakhari","year":"2021","journal-title":"Hum Reproduct Update"},{"key":"R58-20260916","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.rbmo.2013.09.027","article-title":"Efficacy and safety of IVF\/ICSI in patients with severe endometriosis after long-term pituitary down-regulation","volume":"28","author":"van der Houwen","year":"2014","journal-title":"Reproduct BioMedicine"},{"key":"R59-20260916","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/oxfordjournals.humrep.a137114","article-title":"The value of pre-treatment with gonadotrophin releasing hormone (GnRH) analogue in IVF-ET therapy of severe endometriosis","volume":"5","author":"Dicker","year":"1990","journal-title":"Human Reprod"},{"key":"R60-20260916","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.rbmo.2017.05.004","article-title":"GnRH agonist administration prior to embryo transfer in freeze-all cycles of patients with endometriosis or aberrant endometrial integrin expression","volume":"35","author":"SurreyKatz-Jaffe","year":"2017","journal-title":"Reprod Biomed"},{"key":"R61-20260916","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijgo.2007.08.021","article-title":"Ovarian suppression treatment prior to in-vitro fertilization and embryo transfer in Chinese women with stage III or IV endometriosis","volume":"100","author":"Ma","year":"2008","journal-title":"Int J Gynaecol Obstetrics"},{"key":"R62-20260916","first-page":"185","article-title":"Modified super-long down-regulation protocol improved the outcome of in vitro fertilization-embryo transfer in infertile patients","volume":"34","author":"Gong","year":"2009","journal-title":"Zhong Nan Da Xue Bao Yi Xue Ban"},{"key":"R63-20260916","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000214844","article-title":"Gonadotropin-releasing hormone agonist reduces aromatase cytochrome P450 and cyclooxygenase-2 in ovarian endometrioma and eutopic endometrium of patients with endometriosis","volume":"68","author":"Kim","year":"2009","journal-title":"Gynecol Obstetric Investigat Invest"},{"issue":"Suppl 1","key":"R64-20260916","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0015-0282(02)04813-6","article-title":"Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas","volume":"79","author":"Ishihara","year":"2003","journal-title":"Fertility Sterility"},{"key":"R65-20260916","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.xfre.2021.07.003","article-title":"Nonhormonal therapy for endometriosis: a randomized, placebo-controlled, pilot study of cabergoline versus norethindrone acetate","volume":"2","author":"DiVasta","year":"2021","journal-title":"F&S Reports"},{"key":"R66-20260916","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1080\/08941939.2020.1725191","article-title":"Know your enemy: potential role of cabergoline to target neoangiogenesis in endometriosis","volume":"34","author":"Lagan\u00e0","year":"2021","journal-title":"J Investigat Surg"},{"key":"R67-20260916","doi-asserted-by":"crossref","first-page":"167","DOI":"10.5005\/jp-journals-10006-1582","article-title":"Does cabergoline help in decreasing chronic pelvic pain due to endometriosis compared to medroxyprogesterone acetate? A prospective randomized study","volume":"10","author":"Mukhopadhyay","year":"2018","journal-title":"J South Asian Feder Obstet Gynaecol"},{"key":"R68-20260916","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1093\/humrep\/deaa337","article-title":"Use of dopamine agonists to target angiogenesis in women with endometriosis","volume":"36","author":"Pellicer","year":"2021","journal-title":"Human Reproduct"},{"key":"R69-20260916","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1080\/09513590.2022.2133105","article-title":"State of the art, new treatment strategies, and emerging drugs for non-hormonal treatment of endometriosis: a systematic review of randomized control trials","volume":"38","author":"Miku\u0161","year":"2022","journal-title":"Gynecol Endocrinol"},{"key":"R70-20260916","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.fertnstert.2010.10.024","article-title":"Effects of hyperprolactinemia treatment with the dopamine agonist quinagolide on endometriotic lesions in patients with endometriosis-associated hyperprolactinemia","volume":"95","author":"G\u00f3mez","year":"2011","journal-title":"Fertility Sterility"},{"key":"R71-20260916","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-5-75","article-title":"Global gene expression analysis in time series following N-acetyl L-cysteine induced epithelial differentiation of human normal and cancer cells in vitro","volume":"5","author":"Gustafsson","year":"2005","journal-title":"BMC Cancer"},{"key":"R72-20260916","first-page":"57","article-title":"Review paper N-acetylcysteine as an anti-oxidant and anti-inflammatory drug and its some clinical applications","volume":"37","author":"Radomska-Le\u015bniewska","year":"2012","journal-title":"Cent Eur J Immunol"},{"key":"R73-20260916","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1055\/s-0030-1256592","article-title":"Anti-inflammatory efficacy of N-acetylcysteine and therapeutic usefulness","volume":"65","author":"Gillissen","year":"2011","journal-title":"Pneumologie"},{"key":"R74-20260916","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ejogrb.2018.07.002","article-title":"Effectiveness of an antioxidant preparation with N-acetyl cysteine, alpha lipoic acid and bromelain in the treatment of endometriosis-associated pelvic pain: LEAP study","volume":"228","author":"Lete","year":"2018","journal-title":"J Obstet Gynecol Reprod Biol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000005444","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:01:50Z","timestamp":1789556510000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000005444"}},"subtitle":["A Systematic Review and Meta-analysis"],"short-title":[],"issued":{"date-parts":[[2023,11,9]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000005444","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,9]]},"assertion":[{"value":"2023-07-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}